| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Revenue from Contract with Customer, Excluding Assessed Tax | ||||||||
1,065,000 | 1,008,000 | 1,018,000 | 1,009,000 | 941,000 | 903,000 | 923,000 | 1,005,000 | 947,000 |
Cost of sales | ||||||||
863,000 | 833,000 | 821,000 | 809,000 | 764,000 | 744,000 | 757,000 | 822,000 | 771,000 |
Gross profit | ||||||||
202,000 | 175,000 | 197,000 | 200,000 | 177,000 | 159,000 | 166,000 | 183,000 | 176,000 |
Operating expenses: | ||||||||
Selling, general and administrative | ||||||||
222,000 | 201,000 | 216,000 | 205,000 | 186,000 | 133,000 | 132,000 | 139,000 | 143,000 |
Restructuring Costs | ||||||||
- | - | 0 | 0 | - | - | 0 | 6,000 | 1,000 |
Goodwill, Impairment Loss | ||||||||
- | - | 939,000 | - | - | - | 0 | - | - |
Operating loss | ||||||||
-20,000 | -25,000 | -958,000 | -5,000 | -9,000 | 33,000 | 34,000 | 38,000 | 32,000 |
Other income (expense): | ||||||||
Interest income | ||||||||
0 | 2,000 | 1,000 | 2,000 | 2,000 | 2,000 | 1,000 | 1,000 | 2,000 |
Interest expense | ||||||||
14,000 | 13,000 | 16,000 | 15,000 | 12,000 | 1,000 | 0 | 1,000 | 1,000 |
Other, net | ||||||||
-1,000 | -1,000 | 4,000 | 13,000 | 1,000 | 2,000 | 0 | 0 | 1,000 |
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest | ||||||||
-35,000 | -37,000 | -969,000 | -5,000 | -18,000 | 36,000 | 35,000 | 38,000 | 34,000 |
Income Tax Expense (Benefit) | ||||||||
-2,000 | 52,000 | -60,000 | 5,000 | -4,000 | 4,000 | 19,000 | 8,000 | 6,000 |
Equity in earnings of affiliates | ||||||||
- | - | 0 | 0 | - | - | 0 | 1,000 | - |
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | ||||||||
-33,000 | -89,000 | -909,000 | -10,000 | -14,000 | 32,000 | 16,000 | 31,000 | 28,000 |
Less: net loss attributable to redeemable non-controlling interests | ||||||||
0 | 1,000 | -3,000 | 0 | -1,000 | -1,000 | 0 | 2,000 | 5,000 |
Net loss attributable to Covetrus | ||||||||
-33,000 | -90,000 | -906,000 | -10,000 | -13,000 | 33,000 | 16,000 | 29,000 | 23,000 |
Earnings Per Share [Abstract] | ||||||||
Loss per share attributable to Covetrus: (Note 14) | ||||||||
Basic (in usd per share) | ||||||||
-0.30 | -1.18 | -8.09 | -0.09 | -0.14 | 0.47 | 0.22 | 0.40 | 0.32 |
Diluted (in usd per share) | ||||||||
-0.30 | -1.18 | -8.09 | -0.09 | -0.14 | 0.47 | 0.22 | 0.40 | 0.31 |
Weighted-average common shares outstanding: | ||||||||
Basic (in shares) | ||||||||
112,000 | 109,000 | 112,000 | 112,000 | 95,000 | 70,549 | 71,000 | 71,000 | 71,451 |
Diluted (in shares) | ||||||||
112,000 | 109,000 | 112,000 | 112,000 | 95,000 | 72,027 | 72,000 | 72,000 | 71,973 |